
Instylla
Instylla develops liquid embolic products for interventional radiology procedures, primarily targeting cancer treatment and bleeding control. The Bedford-based medical device company has raised $98M and employs 76 people.
The growth story

Instylla grew from 34 to 76 employees between 2021 and 2026, raising $98M along the way, most recently a Series C in October 2025.
About
Instylla makes liquid embolic agents used in minimally invasive procedures to block blood vessels, with applications in cancer therapy and stopping bleeding. Its products are designed for use by interventional radiologists.
The company has raised $98M in funding, most recently in a Series C round in October 2025. With 76 employees, Instylla's workforce is anchored by a sales team of 12 people.
Founders and leadership
Instylla's leadership team has deep experience in medical devices, with many executives coming from major industry players. The company's largest function is sales, which accounts for 12 of its 76 employees.












The Instylla org chart
Sean Boyle (Chief Executive Officer) leads 37 mapped leaders with 13 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew

Headcount by function: Sales 13 (+550% YoY), Business Development 11 (+38% YoY), Research 10 (-9% YoY), Operations 7 (+40% YoY), Engineering 7 (+75% YoY), Quality Assurance 6 (+20% YoY).
Talent flow
Instylla recruits heavily from established medical device companies, with Boston Scientific being its top talent source (13 hires). Other common sources include Medtronic, Augmenix, and AngioDynamics. Employees tend to stay for a median of 4 years.

Most common previous employers of Instylla staff: Boston Scientific (13), Medtronic (6), Augmenix (6), AngioDynamics (6), BD (5), Philips (4). Former Instylla employees most often moved to Johnson & Johnson MedTech (2), LabCentral (1), Werfen (1), Enterra Medical (1), PAVmed (1), Brooke Mastrorio Clinical Consulting (1).
Alumni worth knowing
Hiring now
Web traffic

Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of

Most common skills at Instylla: Medical Devices (38), Leadership (20), Sales (16), Management (16), Microsoft Excel (16), Communication (16), Microsoft Office (16), Customer Service (15).
Where the team actually sits

Instylla people are concentrated in Greater Boston (16), Massachusetts, United States (16), California, United States (3), Florida, United States (3).
Search footprint
Instylla attracts about 44 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 1 ranking keywords and lost 6 in the last period.
What employees say
- Compensation
- 4.00 / 5
- Career opportunities
- 5.00 / 5
Frequently asked
Instylla has 76 employees as of September 2026.
Instylla has raised $98M in total, most recently a Series C round in October 2025.
Sean Boyle (Chief Executive Officer) sits at the top of Instylla's reporting structure, with 13 direct reports.
The most common previous employers of current Instylla staff are Boston Scientific (13 people), Medtronic (6 people), Augmenix (6 people).
Former Instylla employees most often move to Johnson & Johnson MedTech (2), LabCentral (1), Werfen (1).
Instylla attracts about 44 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Instylla staff are Medical Devices, Leadership, Sales, Management, Microsoft Excel.
Instylla staff are concentrated in Greater Boston (16), Massachusetts, United States (16), California, United States (3).
Instylla has about 13 people in Sales, up 550% over the past year, as of September 2026.
Instylla has about 11 people in Business Development, up 38% over the past year, as of September 2026.
Computed from 57 current and 35 former Instylla profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.






